Optimized Page

Menarini Stemline is collaborating with Outcomes4Me to raise awareness of ESR1 mutation testing

Know ESR1 logo

Nearly 1 out of 2 people with ER+/HER2- metastatic breast cancer may develop an ESR1 mutation after progression on hormone therapy.

Another Image on Right
Understand your treatment options banner



MAT-US-DS-00285 11/24